For more than a century, Winthrop-University Hospital’s culture has been
shaped by an ever-deepening commitment
to integrating the highest
quality patient care services with
dynamic medical education programs
and rigorous research initiatives.
Underscoring this mission, the
Board of Directors, clinical faculty and
Administration have moved the Hospital
into a transformative era, exemplified
by the development of a visionary and
robust biomedical Research Institute
with newly recruited basic and clinical
scientists who complement the work of
current investigators.
The collaborative environment
nurtures creative, independent thinking,
the opportunity to share insights and
ideas, and extraordinary teamwork.
Multidisciplinary PhD scientists and
physician investigators are involved in
vigorous basic, clinical, translational
and health outcomes studies. These
include a major commitment that
focuses not only on the causes and consequences
of diabetes, but also on the
disease’s many complex complications
that touch a large pool of patients in
virtually every medical specialty.
The collective goal is to disease and aging.”
improve and solve major
public health problems
with cutting-edge
scientific discoveries…
Winthrop investigators are also
addressing other important public
health issues, including pregnancy
and premature births; improving
treatment of cancer; osteoporosis;
diabetes-related vascular damage;
autoimmune diseases; neurological
disorders, including amyotrophic
lateral sclerosis; the causes and
consequences of obesity; and other
debilitating chronic diseases.
Currently, the Hospital’s scientists
are conducting, as well as developing
new basic and clinical studies in areas
that can have a significant impact on
public health:
- Bone & Mineral Metabolism
- Cancer
- Cardiovascular Health
- Diabetes
- Endocrinology
- Health Outcomes
- Inflammation
- Neuroscience
- Obesity
- Perinatology
- Pulmonology
- Rheumatology, Allergy & Immunology
- Women’s Health
The collective goal is to improve
and solve major public health problems
with cutting-edge scientific
discoveries, which are transformed
into relevant clinical practices at
the patient’s bedside and, ultimately,
kindle outcomes that reduce the
community’s burden of disease.
Alan M. Jacobson, MD
Chief Research Officer,
Winthrop-University Hospital
“Winthrop has made a major commitment
to the expansion of research on
the causes and consequences of diabetes.
Due to the complex nature of
diabetes and its array of complications,
this research has strong
connections to other areas of clinical
care and investigations being carried
out here. I am very enthusiastic
about this opportunity to apply my
three decades of research experience
to Winthrop’s ambitious research
mission, which is focused on some of
today’s most urgent healthcare challenges:
diabetes and cardiometabolic
syndrome; infant prematurity and
perinatal conditions; and chronic
The collective goal is to disease and aging.”
Further enhancing research at
Winthrop is the network established
between the Hospital and major academic
and research institutions
in the region, including Columbia
Presbyterian Medical Center. What’s
more, the Winthrop faculty enjoys strong
partnerships with investigators and clinicians
at Stony Brook University Medical
Center, which utilizes the Hospital as its
Nassau County Clinical Campus.
Additionally, Winthrop is a
member of The Academy for Medical
Development and Collaboration
(AMDeC) Foundation. AMDeC includes
many of New York’s preeminent medical
schools, academic health centers
and research institutions working
together to develop collaborative basic
science and clinical research projects.
In recognition of Winthrop’s unwavering
commitment to the highest
standards of research, the Hospital’s
extensive biomedical research program
is fully accredited by the prestigious
Association for the Accreditation of
Human Research Protection Programs
(AAHRPP).
For more information about
Winthrop’s research programs, call
1-866-WINTHROP.
|
Vol. 20, No. 2
Summer/Fall 2010
Back to Publications
|
